Skip to main content

Jennifer Lund, PhD, MSPH, is a UNC Lineberger Comprehensive Cancer Center member and pharmacoepidemiologist with expertise in cancer health services and comparative effectiveness research.

Associate Professor, Epidemiology
Gillings School of Global Public Health
UNC-Chapel Hill
Cancer Epidemiology

Area of Interest

I conduct pharmacoepidemiologic and comparative effectiveness research with applications to older adult populations and those diagnosed with cancer. The overall objective of my work is to generate robust evidence on the utilization and effects of medical interventions that will inform decisions made by patients, their caregivers, healthcare providers, and policymakers.

Together with a team of trainees and collaborators, my research program draws upon clinical trials, large healthcare databases, and advanced epidemiologic methods to evaluate:

  1. The quality of care received
  2. The effectiveness and safety of treatment options
  3. The role of polypharmacy, multimorbidity, and frailty in treatment selection, adherence, and outcomes

Awards and Honors

  • Fellow Designation, International Society for Pharmacoepidemiology (ISPE), 2021
  • Young Investigator Award, Finalist, International Society of Geriatric Oncology (SIOG), 2019
  • American Society of Preventive Oncology, Honorable Mention, Poster Award, New York, NY, 2018
  • Gordon H. DeFriese Career Development in Aging Research Award, UNC-Chapel Hill, 2015
  • Abstract Achievement Award winner, American Society of Hematology, 2013

Find publications on PubMed

News and Stories

View all related posts